Atlas Trials

The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis

Clinical trial NCT01451489 · TERMINATED

Trial details

NCT number
NCT01451489
Sponsor
Nanjing University School of Medicine
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
FSGS
Start date
2011-10-13
Primary completion
2016-03-23
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.